Varenicline diminished the weight-bearing deficits exhibited by cancer-bearing mice that express PSAM4-GlyR in the NaV1.8-positive neurons (Fig. 8A, red vs black; RMEL, p = 0.0026). The gene discussed is SCN10A; the disease is cancer.